نتایج جستجو برای: quality adjusted life year

تعداد نتایج: 1895131  

Journal: :Revista espanola de cardiologia 2015
Josep Comín-Colet Darío Rubio-Rodríguez Carlos Rubio-Terrés Cristina Enjuanes-Grau Florian S Gutzwiller Stefan D Anker Piotr Ponikowski

INTRODUCTION AND OBJECTIVES Treatment with ferric carboxymaltose improves symptoms, functional capacity, and quality of life in patients with chronic heart failure and iron deficiency. The aim of this study was to assess the cost-effectiveness of ferric carboxymaltose treatment vs no treatment in these patients. METHODS We used an economic model based on the Spanish National Health System, wi...

Journal: :Stroke 2010
Hsin-Yi Lee Jing-Shiang Hwang Jiann-Shing Jeng Jung-Der Wang

BACKGROUND AND PURPOSE Few studies have evaluated the long-term health impact of stroke as categorized into different subtypes. The aim of this study is to quantify the loss of quality-adjusted life expectancy related to ischemic stroke and intracerebral hemorrhage. METHODS The hospital-based cohort, which consisted of 13,194 patients with first-ever stroke onset dates between 1995 and 2007, ...

Journal: :Seizure 2003
RAEBURN B FORBES SHIRLEY MACDONALD SAM ELJAMEL RICHARD C ROBERTS

INTRODUCTION The cost-utility of vagus nerve stimulator (VNS) devices for medically refractory epilepsy has yet to be estimated. METHODS Using a meta-analysis of randomised controlled trials of VNS, we estimate that six people require implantation in order for one person to experience a 50% reduction in seizure frequency. Costs averted from improved epilepsy control were ascertained from publ...

Journal: :AIDS 1998
A M Bayoumi D A Redelmeier

BACKGROUND Practice guidelines recommending Mycobacterium avium complex (MAC) prophylaxis for patients with HIV disease were based on clinical trials in which individuals did not receive protease inhibitors. OBJECTIVE To estimate the cost-effectiveness of strategies for MAC prophylaxis in patients whose treatment regimen includes protease inhibitors. DESIGN Decision analysis with Markov mod...

Journal: :The New England journal of medicine 2005
Gillian D Sanders Ahmed M Bayoumi Vandana Sundaram S Pinar Bilir Christopher P Neukermans Chara E Rydzak Lena R Douglass Laura C Lazzeroni Mark Holodniy Douglas K Owens

BACKGROUND The costs, benefits, and cost-effectiveness of screening for human immunodeficiency virus (HIV) in health care settings during the era of highly active antiretroviral therapy (HAART) have not been determined. METHODS We developed a Markov model of costs, quality of life, and survival associated with an HIV-screening program as compared with current practice. In both strategies, sym...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید